Lilly Sees More Dealmaking as GLP-1 Wins Expand Market
Eli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
Explore how diversified broad market strategies compare to target date funds for retirement. Learn key differences shaping risk, diversification, and long-term growth.
28,533 articlesEli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
A weekly move saw Strategy unload 3,588 BTC, prompting critics and analysts to question whether this level of selling...
Turning Point Brands stock has surged, even as a prominent fund dumped millions in TPB shares. This article breaks do...
Micron reports robust Q3 guidance and signs a five-year strategic deal, fueling optimism that the AI memory cycle cou...
Take-Two is set to report Q4 results after market close, with GTA VI's looming launch shaping investor sentiment. Gui...
Two Harbors Investment Corp. says UWM Holdings failed to submit a revised bid or request more time as the negotiation...
Morgan Stanley filed amended SEC registrations for Ethereum and Solana ETFs, proposing a 14-basis-point sponsorship f...
Investors chasing steady monthly income via QYLD face a trade-off: the cost of covered-call income can outpace Nasdaq...
Jim Cramer signals resilience in the AI-security wave, underscoring a ongoing hunt for the next DeepSeek. Here are fi...
Nebius soars 16% after NVIDIA discloses a 9.3% stake, prompting a rally in AI cloud peers like CoreWeave and Oracle a...
In a surprising turn, anthropic’s claude overtakes chatgpt on the App Store as users rally against OpenAI. The move c...
Binance has filed a defamation lawsuit against the Wall Street Journal in SDNY after a February report alleged sancti...